| 摘要 |
<p>Protein modification-inhibitory compositions which contain as the active ingredient compounds having a tetrazole group or pharmacologically acceptable salts thereof. Compounds having a tetrazole group such as angiotensin receptor blockers are useful in inhibiting protein modification with carbonyl compounds caused by hyperglycemia or oxidation stress. These protein modification inhibitors are free from side effects such as vitamin B6 deficiency.</p> |
